PriceTargets.com logo

NYSE:A - Agilent Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $181.11
  • Forecasted Upside: 31.71 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$137.51 As of 01/21/2022 01:00 AM ET
▼ -1.97 (-1.41%)

This chart shows the closing price for A by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Agilent Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for A and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for A

Analyst Price Target is $181.11
▲ +31.71% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $181.11, with a high forecast of $195.00 and a low forecast of $169.00. The average price target represents a 31.71% upside from the last price of $137.51.

This chart shows the closing price for A for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 11 polled investment analysts is to buy stock in Agilent Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2020
  • 0 strong buy ratings
  • 18 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2021
  • 0 strong buy ratings
  • 18 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2021
  • 0 strong buy ratings
  • 19 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/25/2021
  • 0 strong buy ratings
  • 19 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/23/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/22/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/21/2022

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/23/2021CowenBoost Price TargetHold ➝ Outperform$180.00 ➝ $187.00High
11/23/2021Stifel NicolausBoost Price TargetHold$162.00 ➝ $169.00High
11/23/2021Bank of AmericaBoost Price TargetBuy$177.00 ➝ $179.00High
11/23/2021SVB LeerinkBoost Price TargetOutperform$170.00 ➝ $175.00Low
10/14/2021CowenLower Price TargetOutperform$200.00 ➝ $180.00Low
9/17/2021CowenBoost Price TargetOutperform$165.00 ➝ $200.00Low
8/18/2021CowenBoost Price TargetOutperform$150.00 ➝ $165.00Medium
8/18/2021Jefferies Financial GroupBoost Price TargetBuy$155.00 ➝ $185.00Medium
8/18/2021Wells Fargo & CompanyBoost Price TargetOverweight$150.00 ➝ $180.00Medium
8/18/2021SVB LeerinkBoost Price TargetOutperform$160.00 ➝ $170.00Medium
8/18/2021KeyCorpBoost Price TargetPositive ➝ Overweight$160.00 ➝ $195.00Medium
8/18/2021Stifel NicolausBoost Price TargetHold$136.00 ➝ $162.00Low
8/18/2021Robert W. BairdBoost Price TargetOutperform$144.00 ➝ $170.00Low
8/18/2021CitigroupBoost Price TargetBuy$160.00 ➝ $190.00Low
7/12/2021KeyCorpBoost Price TargetOverweight$157.00 ➝ $160.00Low
6/22/2021Societe GeneraleUpgradeHold ➝ BuyLow
5/26/2021KeyCorpBoost Price TargetOverweight$148.00 ➝ $157.00High
5/26/2021SVB LeerinkBoost Price TargetOutperform$140.00 ➝ $145.00High
5/26/2021Wells Fargo & CompanyBoost Price TargetOverweight$140.00 ➝ $150.00High
5/26/2021Robert W. BairdBoost Price TargetOutperform$137.00 ➝ $144.00High
5/26/2021CitigroupBoost Price TargetBuy$150.00 ➝ $160.00High
3/19/2021Redburn PartnersUpgradeNeutral ➝ BuyLow
3/18/2021CitigroupUpgradeNeutral ➝ Buy$150.00Medium
2/17/2021KeyCorpBoost Price Target$130.00 ➝ $148.00Low
2/17/2021CitigroupBoost Price Target$120.00 ➝ $135.00Low
2/17/2021Robert W. BairdBoost Price TargetOutperform$133.00 ➝ $137.00Low
2/17/2021Wells Fargo & CompanyBoost Price TargetOverweight$120.00 ➝ $140.00Low
2/17/2021CowenBoost Price TargetOutperform$125.00 ➝ $135.00Low
2/17/2021SVB LeerinkBoost Price TargetOutperform$130.00 ➝ $140.00Low
2/17/2021Bank of AmericaUpgradeNeutral ➝ Buy$147.00Low
1/12/2021MizuhoInitiated CoverageBuy$51.00Medium
12/23/2020MKM PartnersInitiated CoverageBuy$57.00N/A
12/15/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$49.00Low
12/10/2020SVB LeerinkBoost Price TargetOutperform$120.00 ➝ $130.00High
12/3/2020Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$130.00Low
11/25/2020UBS GroupUpgradeNeutral ➝ Buy$103.00 ➝ $132.00Low
11/24/2020JPMorgan Chase & Co.Boost Price TargetOverweight$110.00 ➝ $125.00High
11/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$105.00 ➝ $120.00High
11/24/2020Robert W. BairdBoost Price TargetOutperform$104.00 ➝ $118.00High
11/24/2020SVB LeerinkBoost Price TargetOutperform$100.00 ➝ $120.00High
11/17/2020Cleveland ResearchUpgradeNeutral ➝ BuyLow
11/9/2020KeyCorpInitiated CoverageOverweight$130.00High
11/9/2020HSBCUpgradeHold ➝ Buy$30.70High
11/3/2020Morgan StanleyUpgradeEqual Weight ➝ OverweightLow
9/30/2020Atlantic SecuritiesInitiated CoverageNeutral$105.00Low
8/25/2020Stifel NicolausLower Price TargetHold$39.00 ➝ $37.00Low
8/19/2020Bank of AmericaBoost Price TargetNeutral$99.00 ➝ $103.00Low
8/19/2020Stifel NicolausBoost Price TargetHold$85.00 ➝ $100.00Medium
8/19/2020Jefferies Financial GroupBoost Price TargetBuy$95.00 ➝ $110.00Medium
8/19/2020SVB LeerinkBoost Price TargetOutperform$95.00 ➝ $100.00High
8/19/2020Robert W. BairdBoost Price TargetOutperform$87.00 ➝ $104.00High
8/19/2020Needham & Company LLCReiterated RatingHoldHigh
8/19/2020CitigroupBoost Price TargetNeutral$85.00 ➝ $100.00High
8/19/2020Wells Fargo & CompanyReiterated RatingOverweight$100.00 ➝ $105.00High
7/27/2020Credit Suisse GroupBoost Price TargetNeutral$53.00 ➝ $54.00Medium
7/20/2020Bank of AmericaBoost Price TargetNeutral$88.00 ➝ $99.00High
7/13/2020The Goldman Sachs GroupInitiated CoverageNeutralHigh
7/1/2020The Goldman Sachs GroupReiterated RatingBuy ➝ NeutralMedium
5/22/2020CfraLower Price TargetHold$89.00 ➝ $85.00Low
5/22/2020Bank of AmericaBoost Price TargetNeutral$74.00 ➝ $88.00Low
5/22/2020UBS GroupBoost Price TargetNeutral$84.00 ➝ $87.00Medium
5/22/2020CowenBoost Price TargetOutperform$80.00 ➝ $95.00Medium
5/22/2020Wells Fargo & CompanyBoost Price TargetOverweight$82.00 ➝ $95.00Low
5/22/2020SVB LeerinkBoost Price TargetOutperform$90.00 ➝ $95.00Low
4/28/2020Royal Bank of CanadaInitiated CoverageSector PerformLow
4/28/2020UBS GroupLower Price TargetNeutral$90.00 ➝ $84.00Low
4/16/2020SunTrust BanksLower Price TargetHold$90.00 ➝ $75.00Low
4/2/2020Stifel NicolausLower Price TargetHold$85.00 ➝ $73.00Medium
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$100.00 ➝ $82.00Low
3/26/2020BarclaysLower Price TargetEqual Weight$85.00 ➝ $76.00Low
3/20/2020CitigroupLower Price TargetNeutral$85.00 ➝ $75.00Medium
2/24/2020Needham & Company LLCDowngradeBuy ➝ Hold$85.00High
2/21/2020CfraLower Price TargetHold$60.00 ➝ $57.00Low
2/19/2020Piper SandlerBoost Price TargetOverweight$86.00 ➝ $96.00Medium
2/19/2020UBS GroupBoost Price TargetBuy ➝ Neutral$87.00 ➝ $90.00High
2/12/2020HSBCUpgradeHold ➝ BuyLow
1/28/2020UBS GroupReiterated RatingBuyLow
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$100.00 ➝ $100.00Medium
1/6/2020CitigroupInitiated CoverageNeutral$85.00Low
1/3/2020Needham & Company LLCInitiated CoverageBuy$77.00Medium
11/26/2019UBS GroupBoost Price TargetNeutral$82.00 ➝ $87.00Low
11/26/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00 ➝ $90.00High
11/26/2019Needham & Company LLCReiterated RatingBuy$92.00 ➝ $85.00High
11/14/2019Stifel NicolausInitiated CoverageHold$85.00High
10/18/2019UBS GroupDowngradeBuy ➝ Neutral$82.00Medium
10/9/2019BarclaysLower Price TargetEqual Weight$78.00 ➝ $76.00Low
8/19/2019Needham & Company LLCBoost Price TargetBuy$92.00Low
8/15/2019Robert W. BairdReiterated RatingOutperform$79.00 ➝ $82.00High
8/15/2019Piper Jaffray CompaniesBoost Price TargetOverweight$83.00 ➝ $86.00High
7/16/2019Bank of AmericaDowngradeBuy ➝ Neutral$76.00Low
7/15/2019BarclaysDowngradeOverweight ➝ Equal Weight$86.00 ➝ $78.00Low
6/11/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$83.00Low
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/15/2019Bank of AmericaLower Price TargetBuy$88.00 ➝ $82.00High
5/15/2019Deutsche Bank AktiengesellschaftLower Price TargetBuy$90.00 ➝ $85.00High
5/15/2019BarclaysLower Price TargetOverweight$88.00 ➝ $86.00High
3/26/2019CowenBoost Price TargetOutperform ➝ Outperform$80.00 ➝ $90.00Low
3/15/2019UBS GroupInitiated CoverageBuy ➝ Buy$92.00Low
2/25/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$77.00 ➝ $88.00Low
2/21/2019Janney Montgomery ScottReiterated RatingOverweight ➝ Buy$80.00 ➝ $90.00Low
2/21/2019Bank of AmericaReiterated RatingBuy ➝ Buy$78.00 ➝ $87.00Low
2/21/2019BarclaysBoost Price TargetOverweight ➝ Overweight$80.00 ➝ $83.00Low
2/21/2019Deutsche Bank AktiengesellschaftReiterated RatingBuy$90.00Low
2/21/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00Medium
2/20/2019Robert W. BairdReiterated RatingBuy$77.00 ➝ $82.00High
2/12/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$80.00 ➝ $85.00Low
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$77.00High
12/31/2018Alembic Global AdvisorsDowngradeHoldMedium
11/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$86.00 ➝ $89.00Medium
11/12/2018Cleveland ResearchDowngradeBuy ➝ NeutralMedium
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$84.00 ➝ $86.00High
9/18/2018The Goldman Sachs GroupReiterated RatingBuy$77.00 ➝ $82.00Low
9/17/2018The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
8/15/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$77.00 ➝ $80.00Medium
8/15/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$83.00 ➝ $84.00Medium
5/15/2018CowenUpgradeMarket Perform ➝ OutperformHigh
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$95.00 ➝ $91.00Low
4/9/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyMedium
4/2/2018Morgan StanleyBoost Price TargetOverweight$90.00 ➝ $95.00High
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$75.00 ➝ $80.00Low
1/18/2018Robert W. BairdReiterated RatingBuy$76.00Medium
1/8/2018BarclaysReiterated RatingBuy$74.00Low
1/3/2018Evercore ISIInitiated CoverageOutperform$75.00Medium
11/24/2017Robert W. BairdReiterated RatingBuy$72.00N/A
11/22/2017CowenReiterated RatingHold$70.00N/A
11/21/2017BarclaysBoost Price TargetOverweight$67.00 ➝ $71.00N/A
11/21/2017JPMorgan Chase & Co.Boost Price TargetOverweight$75.00N/A
11/21/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$75.00N/A
11/14/2017Morgan StanleyReiterated RatingOverweightN/A
10/20/2017Robert W. BairdReiterated RatingBuy$70.00N/A
9/28/2017CowenReiterated RatingHold$65.00Low
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$68.00Low
8/16/2017Bank of AmericaBoost Price TargetEqual Weight$66.00 ➝ $68.00Medium
8/16/2017Morgan StanleyReiterated RatingOverweightMedium
8/16/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$66.00 ➝ $68.00Medium
8/16/2017Janney Montgomery ScottBoost Price TargetBuy$65.00 ➝ $70.00Medium
8/16/2017JPMorgan Chase & Co.Reiterated RatingOverweight$70.00Low
8/15/2017Bank of AmericaReiterated RatingEqual WeightMedium
8/9/2017Jefferies Financial GroupReiterated RatingBuy$66.00High
7/19/2017BarclaysReiterated RatingBuy$67.00Low
7/12/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$42.92 ➝ $60.73Low
7/10/2017Morgan StanleyReiterated RatingOverweightLow
6/22/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$66.00Medium
5/24/2017Morgan StanleyBoost Price TargetOverweight$65.00 ➝ $70.00Low
5/24/2017BTIG ResearchBoost Price TargetBuy$57.00 ➝ $65.00Low
5/24/2017Robert W. BairdBoost Price TargetOutperform$57.00 ➝ $62.00Low
5/23/2017Jefferies Financial GroupBoost Price TargetBuy$59.00 ➝ $66.00Low
5/23/2017CowenBoost Price TargetMarket Perform$53.00 ➝ $62.00Medium
5/22/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$58.00 ➝ $62.00Low
4/2/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$56.00 ➝ $58.00Low
3/17/2017Jefferies Financial GroupReiterated RatingBuy$59.00Low
3/15/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$62.00High
2/15/2017UBS GroupBoost Price TargetNeutral$48.00 ➝ $50.00N/A
2/13/2017Janney Montgomery ScottBoost Price TargetBuy$55.00 ➝ $60.00N/A
(Data available from 1/22/2017 forward)

News Sentiment Rating

0.37 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/26/2021
  • 7 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Mentions as of
7/26/2021
  • 22 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
8/25/2021
  • 5 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Mentions as of
9/24/2021
  • 5 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
10/24/2021
  • 9 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/23/2021
  • 5 very positive mentions
  • 31 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/23/2021
  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
1/22/2022

Current Sentiment

  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Agilent Technologies logo
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Read More

Today's Range

Now: $137.51
Low: $137.49
High: $140.49

50 Day Range

MA: $152.66
Low: $137.51
High: $164.30

52 Week Range

Now: $137.51
Low: $112.47
High: $179.57

Volume

1,717,722 shs

Average Volume

2,035,009 shs

Market Capitalization

$41.53 billion

P/E Ratio

34.90

Dividend Yield

0.60%

Beta

1

Frequently Asked Questions

What sell-side analysts currently cover shares of Agilent Technologies?

The following equities research analysts have issued stock ratings on Agilent Technologies in the last year: Bank of America Co., Citigroup Inc., Cowen Inc, Jefferies Financial Group Inc., KeyCorp, Redburn Partners, Robert W. Baird, Societe Generale, Stifel Nicolaus, SVB Leerink LLC, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for A.

What is the current price target for Agilent Technologies?

9 Wall Street analysts have set twelve-month price targets for Agilent Technologies in the last year. Their average twelve-month price target is $181.11, suggesting a possible upside of 31.7%. KeyCorp has the highest price target set, predicting A will reach $195.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $169.00 for Agilent Technologies in the next year.
View the latest price targets for A.

What is the current consensus analyst rating for Agilent Technologies?

Agilent Technologies currently has 1 hold rating and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe A will outperform the market and that investors should add to their positions of Agilent Technologies.
View the latest ratings for A.

How do I contact Agilent Technologies' investor relations team?

Agilent Technologies' physical mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company's listed phone number is (800) 227-9770 and its investor relations email address is [email protected]com. The official website for Agilent Technologies is www.agilent.com.